Medical network - February 3, sinolink securities issued "high-value consumables current integration path and opportunities" research report, which analyzes the six medical equipment business, performance of enterprises and we share as follows, reference for the industry. (such as Kant unlisted companies such as music, not on the list of analysis, in the future we have a chance to analysis again).
1, its equipment
Its equipment (CMIC, China medical equipment co., LTD.), founded in 1966, belongs to the group. Upstream downstream services more than 5000 customers, terminal connection more than hundreds of well-known brands at home and abroad. Annual revenue of billions RMB, is currently the nation's largest medical equipment commercial circulation enterprises.
The current national medicine instrument has 23 provinces and cities autonomous region, municipalities directly under the central government in the country to establish the molecular company, large system. Product line covers medical equipment (image), treatment, high-value consumables, low-value consumables, IVD, hemodialysis, such as business model including direct sales, distribution, third-party logistics, department and wait for a variety of patterns.
Its equipment is one of the country's largest medical equipment business, although the size of super billions, but compared with its earning more than $2000, the volume is not. And its equipment involves the product line covers the equipment and consumables, equipment category, specification of the rich, refined into a single product, a lower concentration.
Sinopharm business income is 227.1 billion, 2015, up 13.5% from a year earlier, the net profit of 3.76 billion.
2, kyushu medical apparatus and instruments
Kyushu through medical apparatus and instruments for 2015 operating income of 3.5 billion yuan, up 58% from a year earlier, the listed company 15 years business income is 49.6 billion. Kyushu through medical devices before cover more home medical products. Kyushu in 2015 bought seven orthopaedic dealers and after-sales service companies.
Kyushu with medical devices operating personnel 700 people, the downstream customers in more than 30000, operating products cover medical consumables, family health, family planning supplies, medical equipment, four categories of products, covering the upstream suppliers, including Johnson &johnson medical, Siemens, Austin, bahrain, BD, bayer, omron, jiangsu diving, shenzhen, shenzhen mindray, robust, MSD China, Beijing zizhu, Qingdao durex, etc.
Kyushu on medical devices in addition to business cooperation with manufacturers, also launched a "hospital medical equipment logistics solutions (HPD)" business model, is now in Beijing university people's hospital and so on more than 10 terminal use; And home care products launched terminal overall solution, provide product portfolio selection for retail pharmacies, store display, personnel training, profit analysis and comprehensive service, and vigorously promote the terminal pharmacy sales of medical equipment products.
Kyushu tong equipment more provinces and cities in the country to establish a subsidiary, including Inner Mongolia, henan, shandong, guangdong, guangxi, fujian, xinjiang, gansu, jiangsu, chongqing, Beijing, Shanghai, anhui, zhejiang, liaoning, jiangxi, shanxi.
Kyushu in 2015 to achieve revenue 2015, year-on-year growth of 21%, net profit of 704 million.
# 3, fine things
Fine thing hall began in 2011 into the circulation field of medical equipment. For 11 years, 12 years equipment distribution plate margins are 30% and 30% respectively, were significantly higher than that of fine thing hall overall gross margin level of 9%. After running in two years, 2013 companies in cardiology, consumables as the breakthrough point, layout the high-value consumables distribution business, the acquisition of six heart medicine material circulation enterprises.
As of the first half of 2016, jia business hall to 16 high value material circulation of the company's holdings, 16 consumables company achieve revenue 2.8 billion, net profit 150 million, net interest rate of 5%, more than 2% of company's overall net profit level.
4, rui kang pharmaceutical
Rui kang medical equipment and consumables distribution business in 2012, was set up in the province intervention, bone
Ten division, hemodialysis, equipment sales in the second class above the hospital opening rate from 0.8% at the beginning of growth
To the end of the year 60.4%.
Beginning in 2015, rui kang pharmaceutical holdings for ways to expand outside the province, the newly added 15 equipment sales subsidiaries in 13 companies outside the province, and planning completed three years of the nation's 30 provinces strategic layout. As in the first half of 2016, the company has complete layout in more than 20 provinces.
Rui kang pharmaceutical business income is 9.7 billion, 2015, 1.05 billion medical equipment circulation to achieve revenue.
5, kelly's
Kelly's was founded in 2005, 2012 listed on the gem. Pre-market with PVP and PKP holds the minimally invasive spinal surgery system products, listed by mergers and acquisitions after the trauma, joint surgical instruments of orthopedic implants and the whole industry line layout. And through the acquisition of the layout of the cardiovascular interventional devices field of science and technology, low temperature plasma radiofrequency ablation through agent products into the field of sports medicine, is the domestic high-value consumables industry leading enterprises.
Company in 2015 revenue of 460 million yuan, up 108% from a year earlier, a net profit of 150 million yuan, up 124% from a year earlier, to achieve strong growth.
Are three sources of income before the company in 2015 vertebral body expansion balloon catheter system, spinal and trauma and drug-eluting coronary stent products, the current three major products of equilibrium.
On November 15, 2016, kelly's wholly owned subsidiary technology recently proposed easily with 390 million yuan purchase of ningbo deep strategy wins 100% stake, is mainly engaged in medical high-value consumable materials acquisition target marketing.
Company became the first to high-value consumables channel integration of listed equipment industrial enterprises.
Company in orthopedics, cardiovascular, the layout of the sports medicine, etc, on the company existing, and in the research of the rich product line. Domestic medical equipment industry development up to now, has come to the stage products, channels are equally important, kelly's product lines and channel deployment bring out the best in each other, the future is expected to achieve industrial support business, commercial industry good development momentum.
6, shares thereof
Thereof in the original main business focus on providing medical equipment and hospital center construction departments and disciplines, products and business covers tumor minimally invasive therapy, interventional ultrasound, medical oxygen equipment and engineering, medical clean, medical imaging, rehabilitation and conventional medical equipment, etc.; Chain in the medical services industry, is committed to establish a rehabilitation hospital, cooperate with all levels of hospital construction blood purification center, assist the county hospital development intervention studies. In addition, the company in the field of medical information industry, mobile medical, healthcare, financial platform layout.
Thereof in the progress of the material assets reorganization, according to the progress in restructuring announcement, the company intends to buy Shanghai new medical supply chain management co., LTD. Target company is a focus on high value medical consumables supply chain management of the company, the company is committed to set up an efficient traceability, the whole process can be regulated, the most conforms to the medical institutions procurement mode of centralized and distribution of high value medical consumables and service platforms.
Thereof in 2015 operating income of 790 million, net profit of 106 million. |
